skip to content

Cambridge Immunology Network

 
Consultant Rheumatologist
Director of the Rheumatology Clinical Research Unit at Addenbrooke’s Hospital
Associate Lecturer in the Faculty of Clinical Medicine

Research

Currently Dr Östör’s main research interests include early inflammatory arthritis, biologic therapies and clinical trials for rheumatic diseases. He is involved with the British Society for Rheumatology’s guidelines committee and is a member of the Treat to Target initiative for RA. His other main interests include vitamin D and soft tissue disorders of the upper limb. When not at work he is either exploring a new destination or cycling around Cambridgeshire.

Over the last 10 years Dr Östör has been involved in over 50 clinical trials with a focus on biologic therapy for Rheumatoid Arthritis.

Publications

Key publications: 

Mäki-Petäjä KM, Elkhawad M, Cheriyan J, Joshi FR, Ostör AJ, Hall FC, Rudd JH, Wilkinson IB. Anti-Tumor Necrosis Factor-α Therapy Reduces Aortic Inflammation and Stiffness in Patients With Rheumatoid Arthritis. Circulation. 2012 Nov 20;126(21):2473-80.

Bykerk VP, Ostör AJ, Alvaro-Gracia J, Pavelka K, Ivorra JA, Graninger W, Bensen W, Nurmohamed MT, Krause A, Bernasconi C, Stancati A, Sibilia J. Tocilizumab in patients with active rheumatoid arthritis and inadequate responses to DMARDs and/or TNF inhibitors: a large, open-label study close to clinical practice. Ann Rheum Dis. 2012 May (12):1950-4.

Hadjinicolaou AV, Nisar MK, Bhagat S, Parfrey H, Chilvers ER, Ostör AJ. Non-Infectious Pulmonary Toxicity of Rituximab:a Systematic Review. Rheumatology (Oxford). 2012 Apr;51(4):653-62.

Gout T, Ostör AJ, Nisar MK. Lower gastrointestinal perforation in rheumatoid arthritis patients treated with conventional DMARDs or tocilizumab: a systematic literature review. Clin Rheumatol. 2011;30:1471-4. Epub 2011 Aug 11

Hadjinicolaou AV, Nisar MK, Bhagat S, Parfrey H, Chilvers ER, Ostör AJ. Non-infectious pulmonary complications of newer biological agents for rheumatic diseases--a systematic literature review. Rheumatology (Oxford). 2011 Dec; 50(12):2297-305. Epub 2011 Oct 22

Campbell L, Chen C, Bhagat S, Parker R, Ostor AJ; Risk of adverse events including serious infections in rheumatoid arthritis patients treated with tocilizumab: a systematic literature review and meta-analysis of randomised controlled trials. Rheumatology (Oxford). 2011 Mar; 50(3):552-62.

Other publications: 

The Rheumatology Academy 3rd-4th March 2016.

Click here to access Rheumatology Academy agenda.

Dr Andrew  Östör
Takes PhD students
Available for consultancy

Affiliations

Departments and institutes: 
Person keywords: 
abatacept
tofacitinib
clinical trials
tocilizumab
small molecule treatment
biologic therapy
fostamatinib
TNF
anti-TNF agents
biomarkers
rituximab
drug safety
randomised control trials